Publications

5674 Results

The significance of trisomy 8 in myeloid leukemia: a Southwest Oncology Group (SWOG) study.

Authors
ML Slovak;H Gundacker;SR Wolman;FR Appelbaum
Journal / Conference
American Journal of Human Genetics 69(4):232(#285)
Year
2001
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8750, SWOG-9007, SWOG-9031, SWOG-9034 (EST-3489) (CALGB-9120), SWOG-9129 (INT-0129), SWOG-9333, SWOG-9500

Locally advanced nasopharyngeal cancer

Authors
JF Ensley;E Youseff;H Kim;G Yoo
Journal / Conference
Current Treatment Options in Oncology 2(1):15-23
Year
2001
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8892 (INT-0099) (EST-2388) (RTOG-8817)

Secondary analyis of RTOG 9310: an Intergroup phase II combined modality treatment of primary central nervous system lymphoma with chemotherapy and hyperfractionated radiotherapy

Authors
BJ Fisher;W Sieferheld;C Schultz;L De Angelis;D Nelson;SC Schold;W Curran
Journal / Conference
Int J Radiat Oncol Biol Phys 51(3):166(#297)
Year
2001
Research Committee(s)
Brain
Study Number(s)
SWOG-9310 (INT-0143) (RTOG-93-10)

Dietary supplement use in the prostate cancer prevention trial: implications for prevetion trials.

Authors
ML Neuhouser;AR Kristal;RE Patterson;PJ Goodman;IM Thompson
Journal / Conference
Nutrition and Cancer 39(1):12-18
Year
2001
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes.

Authors
WT Bellamy;L Richter;D Sirjani;C Roxas;B Glinsmann-Gibson;Y Frutiger;TM Grogan;AF List
Journal / Conference
Blood 97(5):1427-1434
Year
2001
Research Committee(s)
Leukemia

Biological response to thalidomide in remitting patients with myelodysplastic syndrome (MDS): evidence for induction of neoplastic vascular endothelial growth factor (VEGF) resistance

Authors
AF Baker;WT Bellamy;BJ Glinsmann-Gibson;R Heaton;A Buresh;TM Grogan;AF List
Journal / Conference
Blood 98(11):353a(#1490)
Year
2001
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

Adjuvant chemo and endocrine therapy for node positive breast cancer. 15 year results of Southwest Oncology Group (SWOG) study 7827

Authors
SE Rivkin;S Green;SJ Altman;JJ Costanzi;AB Cruz;C Giarritta;WR Jewell;RM O'Bryan;CK Osborne
Journal / Conference
Breast Cancer Research and Treatment 69(3):249(#252)
Year
2001
Research Committee(s)
Breast
Study Number(s)
SWOG-7827

Cross-tool communication: from protocol authoring to eligibility determination

Authors
JH Gennari;D Sklar;JS Silva
Journal / Conference
Journal of the American Medical Informatics Assoc Symposium Suppl:199-203
Year
2001

A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients

Authors
DJ Sargent;RM Goldberg;SD Jacobson;JS Macdonald;R Labianca;DG Haller;LE Shepherd;JF Seitz;G Francini
Journal / Conference
New England Journal of Medicine 345(15):1091-1097
Year
2001
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8591(NCI Intergroup #0035)

Standard-dose therapy for multiple myeloma: the Southwest Oncology Group experience

Authors
J Crowley;J Jacobson;R Alexanian
Journal / Conference
Seminars in Hematology 38(3):203-208
Year
2001
Research Committee(s)
Myeloma
Study Number(s)
SWOG-7418, SWOG-7704/05, SWOG-7927/28, SWOG-8229/30, SWOG-8624, SWOG-9028, SWOG-9210